[Kuang Li Biomedical Technology Holdings] Q1 2026 EPS -0.40 NTD
NQ Score
0/100
N1 Content Completeness
6
AI Summary (NQ-processed)
Kuang Li Biomedical released its Q1 2026 financial results, posting revenue of 86 million NTD and a net loss of 38 million NTD, resulting in an EPS of -0.40 NTD.